- Home
- CNSP vs ICCT Comparison
CNSP vs ICCT Comparison
Compare CNSP & ICCT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CNSP
- ICCT
- Stock Information
- Founded
- CNSP 2017
- ICCT 1992
- Country
- CNSP United States
- ICCT United States
- Employees
- CNSP N/A
- ICCT N/A
- Industry
- CNSP Biotechnology: Pharmaceutical Preparations
- ICCT Computer Software: Prepackaged Software
- Sector
- CNSP Health Care
- ICCT Technology
- Exchange
- CNSP Nasdaq
- ICCT Nasdaq
- Market Cap
- CNSP 5.4M
- ICCT 5.2M
- IPO Year
- CNSP 2019
- ICCT N/A
- Fundamental
- Price
- CNSP $0.11
- ICCT $0.16
- Analyst Decision
- CNSP Strong Buy
- ICCT
- Analyst Count
- CNSP 1
- ICCT 0
- Target Price
- CNSP $0.50
- ICCT N/A
- AVG Volume (30 Days)
- CNSP 41.4M
- ICCT 5.9M
- Earning Date
- CNSP 11-15-2024
- ICCT 11-29-2024
- Dividend Yield
- CNSP N/A
- ICCT N/A
- EPS Growth
- CNSP N/A
- ICCT N/A
- EPS
- CNSP N/A
- ICCT N/A
- Revenue
- CNSP N/A
- ICCT $10,266,331.00
- Revenue This Year
- CNSP N/A
- ICCT N/A
- Revenue Next Year
- CNSP N/A
- ICCT N/A
- P/E Ratio
- CNSP N/A
- ICCT N/A
- Revenue Growth
- CNSP N/A
- ICCT 34.56
- 52 Week Low
- CNSP $0.10
- ICCT $0.15
- 52 Week High
- CNSP $137.50
- ICCT $3.20
- Technical
- Relative Strength Index (RSI)
- CNSP 37.06
- ICCT 30.94
- Support Level
- CNSP $0.10
- ICCT $0.17
- Resistance Level
- CNSP $0.13
- ICCT $0.19
- Average True Range (ATR)
- CNSP 0.02
- ICCT 0.04
- MACD
- CNSP 0.00
- ICCT 0.00
- Stochastic Oscillator
- CNSP 8.50
- ICCT 3.55
About CNSP CNS Pharmaceuticals Inc.
CNS Pharmaceuticals Inc is a clinical-stage pharmaceutical company focused on the development of anticancer drug candidates for the treatment of primary and metastatic brain and central nervous system tumors. It is involved in the development of Berubicin, which is a therapy for the treatment of glioblastoma. Glioblastomas are tumors that arise from astrocytes, which are star-shaped cells that make up the supportive tissue of the brain.
About ICCT iCoreConnect Inc. Common stock
iCoreConnect Inc develops and markets secure cloud-based HIPAA compliant software services focused on compliance, workflow/productivity, and electronic health records systems. Its core services technology can be adopted to other vertical markets that require a high degree of secure data communication, such as the legal, financial, and education fields. It markets secure HIPAA compliant cloud-based software as a service (SaaS) offering under the names of iCoreExchange, iCoreCodeGenius, iCoreSecure, iCoreMD, iCoreDental, iCoreMobile, iCoreHuddle, iCoreRx, iCorePDMP, iCoreEPCS, and iCorePay. The company's software is sold under annual recurring revenue subscriptions. The company has a single reporting segment for reporting purposes focused on the North American market.